Feeds:
Posts
Comments

Posts Tagged ‘Harvard Medical School’

URO TODAY: A  gene fusion common in cancer patients called TMPRSS2-ERG is associated with worse prognosis in men with prostate cancer, Harvard Medical School researchers have found, with higher tumor stage and tumor-specific death or metastasis. READ MORE>

Read Full Post »

HARVARD MEDICAL SCHOOL: Two international and large randomised studies provide the most convincing evidence thus far that PSA based testing does nothing or meaningfully little to reduce the death rate from prostate cancer and confirm many earlier studies that came to the same conclusions. In this VIDEO, Marc Garnick, MD, discusses the implications. VIEW HERE>

Read Full Post »

BIO-MEDICINE: A new Harvard Medical School website provides multiple perspectives on how best to treat prostate disease, including prostate cancer, benign prostatic hyperplasia (BPH), and prostatitis, as well as erectile dysfunction and low testosterone levels. READ MORE>

Read Full Post »